AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

CVE:TLTTheralase Technologies Stock Price, Forecast & News

C$0.24
-0.02 (-5.88 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.24
Now: C$0.24
C$0.27
50-Day Range
C$0.18
MA: C$0.22
C$0.29
52-Week Range
C$0.14
Now: C$0.24
C$0.52
Volume479,973 shs
Average Volume342,983 shs
Market CapitalizationC$48.91 million
P/E RatioN/A
Dividend Yield2.03%
BetaN/A
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to destroy various cancers in Canada, the United States, and internationally. It operates in two divisions, Anti-Cancer Therapy and Medical Laser Technology. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1995 and is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.60 out of 5 stars


Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-416-6995273

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$964,051.00
Cash FlowC$0.06 per share
Book ValueC$0.07 per share

Profitability

Miscellaneous

Employees20
Market CapC$48.91 million
Next Earnings Date6/4/2020 (Estimated)
OptionableOptionable

Receive TLT News and Ratings via Email

Sign-up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter.

Theralase Technologies (CVE:TLT) Frequently Asked Questions

How has Theralase Technologies' stock been impacted by COVID-19 (Coronavirus)?

Theralase Technologies' stock was trading at C$0.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TLT stock has decreased by 4.0% and is now trading at C$0.24. View which stocks have been most impacted by Coronavirus.

When is Theralase Technologies' next earnings date?

Theralase Technologies is scheduled to release its next quarterly earnings announcement on Thursday, June 4th 2020. View our earnings forecast for Theralase Technologies.

Has Theralase Technologies been receiving favorable news coverage?

Press coverage about TLT stock has been trending somewhat negative this week, according to InfoTrie. The research group identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Theralase Technologies earned a news impact score of -1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutTheralase Technologies.

Who are some of Theralase Technologies' key competitors?

What other stocks do shareholders of Theralase Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theralase Technologies investors own include IMRIS (IMRSQ), Aurora Cannabis (ACB), Cross Timbers Royalty Trust (CRT), Heat Biologics (HTBX), Sesen Bio (SESN), AGNC Investment (AGNC), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Enable Midstream Partners (ENBL) and Ford Motor (F).

Who are Theralase Technologies' key executives?

Theralase Technologies' management team includes the following people:
  • Ms. Kristina Hachey, CFO & Director
  • Dr. Arkady Mandel, Chief Scientific Officer & Director
  • Mr. Roger John Dumoulin-White, Director of Bus. Devel.
  • Dr. Shawn Shirazi Ph.D., Chief Exec. Officer
  • Mr. David M. Groves B.A, Pres of World Trade Division

What is Theralase Technologies' stock symbol?

Theralase Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "TLT."

How do I buy shares of Theralase Technologies?

Shares of TLT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Theralase Technologies' stock price today?

One share of TLT stock can currently be purchased for approximately C$0.24.

How big of a company is Theralase Technologies?

Theralase Technologies has a market capitalization of C$48.91 million and generates C$964,051.00 in revenue each year. Theralase Technologies employs 20 workers across the globe.

What is Theralase Technologies' official website?

The official website for Theralase Technologies is theralase.com.

How can I contact Theralase Technologies?

Theralase Technologies' mailing address is 1945 Queen St E, TORONTO, ON M4L 1H7, Canada. The company can be reached via phone at +1-416-6995273.

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.